Get all your news in one place.
100's of premium titles.
One app.
Start reading
Chicago Tribune
Chicago Tribune
Business
Lisa Schencker

Federal government to penalize AbbVie over the price of its blockbuster drug Humira

North Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the federal government said Wednesday.

The penalty follows years of criticism over the price of Humira and legal maneuvering by AbbVie that staved off competition for the drug in the U.S. until this year.

AbbVie did not immediately respond to requests for comment Wednesday morning.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.